| Overview |
| bsm-90131r-50µL |
| AMPK alpha 1 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human AMPK alpha 1 |
| 500-559/559 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 5562 |
| Q13131 |
| PRKAA1; Protein Kinase AMP-Activated Catalytic Subunit Alpha 1; 5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-1; Protein Kinase AMP-Activated Alpha 1 Catalytic Subunit; Hydroxymethylglutaryl-CoA Reductase Kinase; Acetyl-CoA Carboxylase Kinase; Tau-Protein Kinase PRKAA1; AMPK Subunit Alpha-1; AMPK Alpha 1; ACACA Kinase; HMGCR Kinase; EC 2.7.11.1; AMPKa1; 5'-AMP-Activated Protein Kinase Catalytic Alpha-1 Chain; AMP-Activated Protein Kinase Catalytic Alpha-1; AMP -Activate Kinase Alpha 1 Subunit; AMPK Alpha 1; EC 2.7.11.27; EC 2.7.11.31; EC 2.7.11.26; EC 2.7.11; AMPKA1; AMPK1; AMPK |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz